Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvi Japan Oppo. Regulatory News (AJOT)

Share Price Information for Avi Japan Oppo. (AJOT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 129.00
Bid: 125.00
Ask: 131.00
Change: 0.00 (0.00%)
Spread: 6.00 (4.80%)
Open: 129.00
High: 0.00
Low: 0.00
Prev. Close: 129.00
AJOT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AVI Submits Shareholder Proposals to SK Kaken

18 May 2023 07:00

RNS Number : 7842Z
AVI Japan Opportunity Trust PLC
18 May 2023
 

AVI Japan Opportunity Trust PLC ("AJOT" or the "Company")

 

LEI: 894500IJ5QQD7FPT3J73

18 May 2023

London

 

AVI Submits Shareholder Proposals to SK Kaken for the Third Year in a Row as the Founding Family Continues to Ignore Support from Shareholders for Change

 

London, 18 May 2023 - Asset Value Investors ("AVI") announces today that it has submitted shareholder proposals to SK Kaken Co., Ltd. (TSE 4628) ("SK Kaken" or the "Company") addressing two issues contributing to the Company's poor share price performance, low valuation, and potential delisting from the Tokyo Stock Exchange ("TSE").

 

A presentation outlining AVI's rationale for changes and full details of the shareholder proposals is available on AVI's dedicated website www.paintingabetterSKKaken.com.

 

Despite a high-quality business model and having a dominant share of the domestic construction paint market, SK Kaken trades on an EV/EBIT ratio of less than 0.8x and a price-to-book ratio of just 0.8x[1]. Over the last five years, SK Kaken's share price has fallen -19%, while its domestic peers'[2] share price has risen +13% and the TOPIX has gained +31%. With 410 shareholders, SK Kaken only narrowly meets the requirements for listing on the TSE Standard market.

 

Joe Bauernfreund, CEO of AVI, comments: "SK Kaken's issues reflect a lack of urgency and weak management discipline, a symptom often encountered at a company with a controlling shareholder. Over 40% of SK Kaken's shares are owned by, and key senior executive positions held by, members of the founding Fujii family."

 

"The average tenure of the SK Kaken board is 15 years and the Founder has a major influence on the decision-making process. This leads to a culture of intransigence and traditionalism, starving the Company of progress."

 

"We submitted shareholder proposals last year and the year before, and despite receiving strong support from non-Fujii family shareholders, SK Kaken has failed to reduce its excess treasury shares and raise its low dividend pay-out ratio."

 

AVI has been a large minority shareholder and owner of SK Kaken for over five years. Due to a lack of progress and the Fujii family's refusal to engage in strategic discussion, AVI is again seeking to enhance SK Kaken's corporate value through submitting shareholder proposals. Although more radical reform is needed than can be addressed through shareholder proposals alone, we have identified two easily addressable issues, aimed at sustainably enhancing SK Kaken's corporate value.

 

(1) The cancellation of 90% of the 438,400 shares held in treasury. SK Kaken currently holds 14% of outstanding shares in treasury and has not put forward any plans to use the shares to complete M&A or improve executive compensation, for example.

 

(2) Increase the dividend from Y400 per share to Y800, representing a 30% payout ratio. SK Kaken has hoarded earnings on its balance sheet, with cash and equivalents accounting for 71% of balance sheet assets.

 

AVI is calling on its fellow shareholders to continue to express their disapproval of poor management policies, which are negatively influenced by a controlling shareholder who has repeatedly neglected minority shareholder interests.

 

 

***

 

AVI at a glance

 

AVI is an investment management company, established in 1985 in London, United Kingdom, that has been invested in Japanese equities for more than 20 years. In addition to managing other funds, AVI namely manages the AVI Global Trust (AGT) and the AVI Japan Opportunities Trust, which, as of 31 March 2023, have total gross assets of JPY190bn (£1.2bn) and JPY31bn (£0.19bn) respectively. AGT and AJOT are publicly listed and trade on the London Stock Exchange's Main Market.

 

AVI has signified its commitment to the "Principles for Responsible Institutional Investors: Japan's Stewardship Code". In accordance with this commitment, AVI engages in constructive "purposeful dialogue" with management and board members, to objectively contribute to the enhancement of corporate value and achieve sustainable growth for its portfolio companies.

 

 

Contact:

Asset Value Investors Limited

Daniel Lee

daniel.lee@assetvalueinvestors.com

 


[1] Source from CapitalIQ as at 30/04/2023

[2]Nippon Paint (4612) and Kansai Paint (4613). TOPIX total return. Source, CapitalIQ.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBLGDUUBBDGXR
Date   Source Headline
21st Oct 20221:41 pmRNSNet Asset Value(s)
21st Oct 202211:02 amRNSResearch from QuotedData
20th Oct 202211:39 amRNSNet Asset Value(s)
19th Oct 20222:07 pmRNSNet Asset Value(s)
19th Oct 20229:45 amRNSQuarterly Newsletter
19th Oct 20229:32 amRNSMonthly update
18th Oct 202212:40 pmRNSNet Asset Value(s)
17th Oct 202211:38 amRNSNet Asset Value(s)
14th Oct 202212:50 pmRNSNet Asset Value(s)
13th Oct 202212:02 pmRNSNet Asset Value(s)
12th Oct 20221:56 pmRNSNet Asset Value(s)
11th Oct 202212:48 pmRNSNet Asset Value(s)
10th Oct 20222:39 pmRNSNet Asset Value(s)
7th Oct 202212:51 pmRNSNet Asset Value(s)
6th Oct 202211:57 amRNSNet Asset Value(s)
5th Oct 202212:01 pmRNSNet Asset Value(s)
4th Oct 202212:27 pmRNSNet Asset Value(s)
3rd Oct 20225:06 pmRNSTransaction in Own Shares
3rd Oct 20222:07 pmRNSNet Asset Value(s)
30th Sep 20221:21 pmRNSNet Asset Value(s)
29th Sep 202211:05 amRNSNet Asset Value(s)
28th Sep 202212:57 pmRNSNet Asset Value(s)
28th Sep 202210:54 amRNSInvestment Manager Increases Holding
28th Sep 20227:00 amRNSHalf-year Report
27th Sep 20223:15 pmRNSNet Asset Value(s)
26th Sep 20222:47 pmRNSNet Asset Value(s)
23rd Sep 20221:44 pmRNSNet Asset Value(s)
22nd Sep 202212:23 pmRNSNet Asset Value(s)
21st Sep 20222:04 pmRNSNet Asset Value(s)
20th Sep 20223:06 pmRNSMonthly Update
20th Sep 202212:55 pmRNSNet Asset Value(s)
16th Sep 202211:39 amRNSNet Asset Value(s)
15th Sep 202212:46 pmRNSNet Asset Value(s)
14th Sep 202212:54 pmRNSNet Asset Value(s)
13th Sep 202212:14 pmRNSNet Asset Value(s)
12th Sep 202212:40 pmRNSNet Asset Value(s)
9th Sep 20221:50 pmRNSNet Asset Value(s)
8th Sep 202212:53 pmRNSNet Asset Value(s)
7th Sep 202212:56 pmRNSNet Asset Value(s)
6th Sep 202212:41 pmRNSNet Asset Value(s)
6th Sep 20227:00 amRNSUpdate on consultation regarding Exit Opportunity
5th Sep 202212:36 pmRNSNet Asset Value(s)
2nd Sep 20222:07 pmRNSNet Asset Value(s)
1st Sep 20222:33 pmRNSNet Asset Value(s)
31st Aug 202212:34 pmRNSNet Asset Value(s)
30th Aug 20221:21 pmRNSNet Asset Value(s)
26th Aug 202212:57 pmRNSNet Asset Value(s)
26th Aug 20229:57 amRNSCompliance with Market Abuse Regulation
25th Aug 20221:22 pmRNSNet Asset Value(s)
24th Aug 20221:06 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.